文献速递乳腺癌放疗放疗物理与技术姑息放疗与转移瘤

NK细胞联合放疗在三阴性乳腺癌人源模型中显示长期疗效与抗转移作用

Combined NK Cell Therapy and Radiation Therapy Exhibit Long-Term Therapeutic and Antimetastatic Effects in a Human Triple Negative Breast Cancer Model.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-10-10

本研究在人三阴性乳腺癌异种移植模型中,探讨体外活化扩增的自然杀伤(NK)细胞过继免疫治疗能否增强局部肿瘤放疗的疗效。MDA-MB-231/Luc-GFP细胞接种于NSG小鼠大腿皮下,分为对照、放疗、NK、放疗+NK四组。结果显示,联合组原发肿瘤荧光信号显著低于同等大小的放疗组肿瘤,NK细胞向原发灶迁移与浸润更持久,腋窝淋巴结转移及肝肺转移受到高度抑制,长期生存显著优于单用放疗或单用NK细胞。

要点

  • 放疗+NK联合组的原发肿瘤荧光信号显著低于同等大小的单纯放疗组。
  • 联合组NK细胞向原发灶的长期迁移与浸润显著高于单用NK细胞组。
  • 联合组腋窝淋巴结转移及肝、肺转移受到高度抑制,长期生存显著优于单药组。

核心结论

  • 放疗降低肿瘤负荷后联合全身NK细胞治疗,可增强原发肿瘤生长抑制,并有效抑制淋巴道播散及肺、肝远处转移,联合组长期生存显著优于单用放疗或单用NK细胞。

研究设计与样本

  • 人三阴性乳腺癌MDA-MB-231/Luc-GFP细胞皮下接种于NSG小鼠大腿,分为对照、RT、NK、RT+NK四组。
  • 健康供者来源NK细胞经体外扩增;种瘤后第17天对放疗组肿瘤照射,第17、19天静脉输注扩增NK细胞两次。
  • 采用长期生物发光成像评估原发与继发肿瘤,并对切除肿瘤组织行组织病理学检查。

主要发现

  • RT+NK组原发肿瘤荧光信号显著低于同等大小的RT组肿瘤。
  • RT+NK组NK细胞向原发灶的长期迁移与浸润显著高于NK组,且NK细胞在原发组织内维持时间显著更长。
  • BLI与p53免疫组化显示RT+NK组腋窝淋巴结转移及肝、肺转移受到高度抑制。
  • RT+NK组长期生存显著高于RT组或NK组。

临床怎么用

  • 结果来自人三阴性乳腺癌NSG小鼠异种移植模型,提示局部放疗与全身NK细胞过继治疗联合可能同时增强局部控制与抗转移效果。
  • 原文未报告临床剂量、输注数量或人体研究数据,临床转化前仍需进一步验证。

局限性

  • 证据仅来自人三阴性乳腺癌NSG小鼠异种移植模型的临床前实验。
  • 原文摘要未报告样本量、具体统计值与P值,无法评估效应量大小。
  • NK细胞来源于健康供者并经体外扩增,与临床可及性和免疫微环境存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated whether adoptive cell therapy with ex vivo-activated natural killer (NK) cells enhances the therapeutic efficacy of local tumor radiation therapy (RT) using a human triple-negative breast cancer xenograft model. METHODS AND MATERIALS: NK cells from healthy donors were expanded ex vivo. MDA-MB-231/Luc-GFP cells were subcutaneously implanted into the thighs of NSG mice. The animals were divided into 4 experimental groups: control, RT, NK, and RT + NK. On day 17 after tumor implantation, tumors from the RT groups were irradiated. The ex vivo-expanded NK cells were intravenously administered twice, on days 17 and 19. Primary and secondary tumors were evaluated using long-term bioluminescence imaging, and histopathology was performed on resected tumor tissue specimens. RESULTS: The luciferase signals of the primary tumors in the RT + NK group were significantly lower than those of comparably sized primary tumors in the RT group. The long-term migration and infiltration of NK cells into the primary tumor sites were significantly higher in RT + NK than in NK mice. Moreover, lymphatic metastasis to the axillary lymph nodes and liver and lung metastases were highly suppressed in the RT + NK group, as demonstrated by BLI and p53 immunohistochemistry. The long-term survival of the RT + NK group was significantly higher than that of the RT or NK groups. CONCLUSIONS: Reduction in tumor burden by combining RT and systemic NK cell therapy improved the suppression of primary tumor growth, with efficient NK cell migration and penetration into the primary tumor site. Administered NK cells were maintained in the primary tissue for a significantly longer time in RT + NK group compared with NK group. Both lymphatic spread and distant metastasis to the lungs and liver were effectively suppressed by the combined therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Kim KW, Jeong JU, Lee KH, et al. Combined NK Cell Therapy and Radiation Therapy Exhibit Long-Term Therapeutic and Antimetastatic Effects in a Human Triple Negative Breast Cancer Model. Int J Radiat Oncol Biol Phys. 2019. PMID: 31605787. doi:10.1016/j.ijrobp.2019.09.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。